Category:Malignant solid neoplasm, ERBB2-mutated medications

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 20:30, 26 April 2018 by Jwarner (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Medications with some degree of efficacy in the treatment of HER2+ tumors, regardless of anatomic site of origin.

Pages in category "Malignant solid neoplasm, ERBB2-mutated medications"

The following 5 pages are in this category, out of 5 total.

N

Neratinib (Nerlynx)

P

Pertuzumab (Perjeta)

T

Retrieved from "https://hemonc.org/w/index.php?title=Category:Malignant_solid_neoplasm,_ERBB2-mutated_medications&oldid=77970"

Site-agnostic medications